Home » Daiichi, Toshiba, and Toshiba Hokuto to Develop Array-Based IVD

Daiichi, Toshiba, and Toshiba Hokuto to Develop Array-Based IVD

Jul 11, 2006
NEW  YORK (GenomeWeb News) - Daiichi Pure Chemicals, Toshiba, and Toshiba Hokuto Electronics plan to co-develop microarray-based in vitro diagnostic systems and chips, the companies said today.
 
Under the agreement, the companies will first develop an IVD for human papilloma virus.
 
Daiichi Pure Chemicals and Toshiba have collaborated on the system since January 2004.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Cells of Something Else

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

SCID Treatment Funded in UK

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Call to Undo Brazilian Cuts

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

This Week in PLOS

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.

What's Popular?

In Microarrays & Multiplexing

  1. Studies Spell Out Common, Rare Variants Contributing to Breast Cancer Susceptibility

  2. Food Allergy GWAS Leads to Five Susceptibility Loci

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.